Spectris PLC

Director's Dealing • Mar 27, 2025

National Storage Mechanism | Additional information

RNS Number : 5619C

Spectris PLC

27 March 2025

Spectris plc: Director/PDMR Shareholding

This notification made under Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

On 27 March 2025, Spectris plc (the "Company") was notified that on the 26 March 2025, Andrew Heath, Chief Executive, and Derek Harding, President, Spectris Scientific acquired 61,399 and 47,808 ordinary shares of 5p each ("Ordinary Shares") in the Company respectively following the exercise of options granted under the terms of the Spectris Long Term Incentive Plan ("LTIP") on 25 March 2020.

Of the 61,399 Ordinary Shares acquired by Mr Heath, 28,994 were sold to fund the option cost and the income tax / national insurance liability at a sale price of £24.1972 and the remaining 32,405 Ordinary Shares were retained and immediately transferred into a nominee account on his behalf.

Of the 47,808 Ordinary Shares acquired by Mr Harding, 22,577 were sold to fund the option cost and the income tax / national insurance liability at a sale price of £24.1972 and the remaining 25,231 Ordinary Shares were retained and immediately transferred into a nominee account on his behalf.

The forms for this transaction, as required under MAR, follows:

1	Details of the persons discharging managerial responsibilities
a)	N a m e(s)	Andrew Heath, Chief Executive
2	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spectris plc
b)	LEI	213800Z4CO2CZO3M3T10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 5p each GB0003308607

b)	Nature of the transaction	(i)   Exercise of options over 61,399 Ordinary Shares under the terms of the LTIP granted on 25 March 2020. (ii)   Subsequent sale of 28,994 Ordinary Shares to cover option cost and income tax / national Insurance liabilities arising on exercise. (iii)  Transfer of remining 32,405 Ordinary Shares into a nominee account on Mr Heath's behalf.
c)	Price(s) and volume(s)	Price(s)	V o l u m e (s)
---	---	---	---	---
(i)   Acquisition £0.05 £0.00	54,510 (Share Award granted as a nominal cost option under the terms of the LTIP) 6,889 (Dividend equivalent shares awarded in lieu of dividend accrual on nominal cost option)
---	---	---	---	---
		(ii)   Sale £24.1972	28,994
---	---	---	---	---
		(iii)  Transfer £nil	32,405
---	---	---	---	---
d)	Aggregated information	(i)   Acquisition
---	---	---	---	---
Price per share		£0.0444
---	---	---	---	---
Volume		61,399
---	---	---	---	---
		Price		£2,725.50
---	---	---	---	---
		(ii)   Sale
---	---	---	---	---
		Price per share		£24.1972
---	---	---	---	---
		Volume		28,994
---	---	---	---	---
		Price		£701,573.62
---	---	---	---	---
		(iii)  Transfer
---	---	---	---	---
		Price per share		£0.0000
---	---	---	---	---
		Volume		32,405
---	---	---	---	---
		Price		£0.00
---	---	---	---	---
e)	Date of the transaction	26 March 2025
---	---	---	---	---
f)	Place of the transaction	Outside of a trading venue
---	---	---	---	---

1	Details of the persons discharging managerial responsibilities
a)	N a m e(s)	Derek Harding, President Spectris Scientific
2	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spectris plc
b)	LEI	213800Z4CO2CZO3M3T10
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 5p each GB0003308607
b)	Nature of the transaction	(i)   Exercise of options over 47,808 Ordinary Shares under the terms of the LTIP granted on 25 March 2020. (ii)   Subsequent sale of 22,577 Ordinary Shares to cover option cost and income tax / national Insurance liabilities arising on exercise. (iii)  Transfer of remaining 25,231 Ordinary Shares into a nominee account on Mr Harding's behalf.
c)	Price(s) and volume(s)	Price(s)	V o l u m e (s)
(i)   Acquisition £0.05 £0.00	42,445 (Share Award granted as a nominal cost option under the terms of the LTIP) 5,363 (Dividend equivalent shares awarded in lieu of dividend accrual on nominal cost option)
		(ii)   Sale £24.1972	22,577
		(iii)  Transfer £nil	25,231

d)	Aggregated information	(iv)  Acquisition
Price per share	£0.0444
Volume	47,808
		Price	£2,122.25
		(v)  Sale
		Price per share	£24.1972
		Volume	22,577
		Price	£546,300.18
		(vi)  Transfer
		Price per share	£0.0000
		Volume	25,231
		Price	£0.00
e)	Date of the transaction	26 March 2025
f)	Place of the transaction	Outside of a trading venue

Name of contact and telephone number for queries:

Stephanie Dyer

Group Reward Executive

07386 686 720

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Date: 27 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPUBAWUPAGCM